Why BGPT?
logo

Review Papers Claim by Claim

Check each claim against its experiments, reported results, scope, and stated limitations.Know what the science actually supports before you trust the answer.

Press Enter ↡ to start review


     Quick Explanation



    Dow et al. (2015) established the doxycycline-inducible iCRISPR mouse system, achieving >90% biallelic dual-gene disruption in ESCs and 50-85% in vivo indels in intestine/thymus, with paired-nickase Cas9n reducing off-targets while maintaining phenotype. Quality is high; main limits are leaky Cas9 (33% clones), mosaic p53 loss, and non-genome-wide off-target screening.


     Long Explanation



    Core Achievement

    Dow et al. engineered a col1a1-targeted TRE3G-Cas9 transgene (c3GIC9) with U6-sgRNA cassettes enabling doxycycline-regulated genome editing in adult mice .

    Strengths

    • Frame-shift ratios (~2:1 in ESCs; 97% Apc frameshift in intestine) demonstrate fitness-dependent selection, a clever internal readout of gene function .
    • Phenotypic validation recapitulates canonical Apc knockout: Wnt target induction (cMyc 130-fold), hyperproliferation, blocked differentiation.
    • Cas9n paired sgRNAs matched Cas9 efficiency in vivo while abolishing the Elk3 off-target β€” practical specificity gain.

    Limitations & Blindspots

    33% of ESC clones showed off-doxycycline mutagenesis (leaky Cas9), and 9.6% of F1 offspring carried identical heterozygous mutations, managed only by clonal screening. Off-target assessment surveyed 18 predicted sites with Surveyor β€” not genome-wide; later unbiased methods (e.g., Digenome-seq) exist . NHEJ-driven indel heterogeneity means 'knockout' is a population mosaic, unlike discrete Cre/lox deletions β€” authors acknowledge this but mosaicism of p53 staining shows incomplete penetrance. Small n (n=4 tissues, 2 ESC clones) limits power for subtle effects; animal studies were not blinded.

    What Would Change the Verdict

    Genome-wide off-target sequencing showing frequent unrepaired damage, or failure to reproduce intestinal phenotype in independent iCRISPR strains, would undermine the platform's value; neither is reported here.



    Feedback:    

    Updated: October 08, 2026

     BGPT Paper Review



    Study Novelty

    90%

    First demonstration of doxycycline-inducible, transgene-based in vivo CRISPR editing in adult mice (2015), complementing contemporaneous viral approaches.



    Scientific Quality

    80%

    Rigorous multi-level validation (ESCs, organoids, in vivo) with honest acknowledgment of leaky expression and off-targets; weaknesses: small n, Surveyor-based off-target screening, no blinding.



    Study Generality

    80%

    Platform logic (TRE-rtTA + sgRNA cassettes) generalizes across tissues and genes; proof shown in intestine, thymus, liver.



    Study Usefulness

    90%

    Widely adopted template for inducible GEMM modeling; enables conditional knockouts in <6 months without loxP allele engineering.



    Study Reproducibility

    70%

    Detailed methods, but c3GIC9 vectors unavailable via Addgene (TRE3G restriction) and off-dox clone screening adds stochasticity.



    Explanatory Depth

    70%

    Mechanistic insights via frameshift-selection ratios and indel-size analysis; limited molecular depth on off-target and NHEJ determinism.


    🎁 Authors: Collect 500 Free Science Tokens (β‰ˆ $50.0 USD)

    Claim My Author Tokens

    Use for 125 days of free BGPT access (4 tokens = 1 day) or trade/sell (β‰ˆ $50.0 USD)

     Top Data Sources ExportMCP



     Analysis Wizard



    Simulating indel frequency accumulation over doxycycline exposure days using reported 2-d, 4-d, and 10-d kinetic constraints, with Monte Carlo uncertainty bands for power planning.



     Hypothesis Graveyard



    iCRISPR replaces Cre/loxP β€” authors explicitly reject; NHEJ heterogeneity and mosaicism make it complementary.


    Viral CRISPR delivery is superior in vivo β€” restricted to injectable tissues; transgenic iCRISPR covers any rtTA-expressing tissue.

     Science Art


    Paper Review: Inducible in vivo genome editing with CRISPR-Cas9 Science Art

     Science Movie



    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT